Skip to Content

What type of drug is Calquence?

Answers (1)

Official Answer by Drugs.com 23 Jan 2018

Calquence (acalabrutinib) is a kinase inhibitor; specifically a highly selective, potent, Bruton tyrosine kinase (BTK) inhibitor for the treatment of mantle cell lymphoma (MCL). Calquence blocks the action of certain enzyme proteins in the body, which can interfere with the growth and spread of cancer cells. Calquence, from AstraZeneca, was FDA approved in October 2017.

Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What disease is Elzonris (tagraxofusp-erzs) used to treat?

Updated 7 Jan 2019 1 answerFAQ by Drugs.com

How do you use the ProAir Digihaler?

Updated 7 Jan 2019 1 answerFAQ by Drugs.com

How many biosimilars have been approved in the United States?

Updated 8 Jan 2019 1 answerFAQ by Drugs.com

What are the brands of sumatriptan?

Updated 5 Feb 2019 1 answerFAQ by Drugs.com

What is botulinum toxin used to treat?

Updated 14 Feb 2019 1 answerFAQ by Drugs.com